Drug intelligence / Profile preview

Qiyao Xiaoke (Zhu Xianyi Memorial Hospital)

Development stage: Unknown
Lead developer: Zhu Xianyi Memorial Hospital
Administration: Oral

Overview

Qiyao Xiaoke is a Traditional Chinese Medicine (TCM) oral liquid formulation developed by the Tianjin Medical University Metabolic Disease Hospital. It is primarily investigated for the treatment of erectile dysfunction (ED) in men with type 2 diabetes mellitus. The formulation is designed based on TCM principles to address "Xiaoke" (the TCM term for diabetes) and its associated complications. Clinical evaluation has focused on assessing the efficacy, safety, and long-term effects of the oral liquid on sexual function in the diabetic patient population.

Other names: Qiyao Xiaoke Oral Liquid

Beyond the preview

Go deeper on Qiyao Xiaoke (Zhu Xianyi Memorial Hospital).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Qiyao Xiaoke (Zhu Xianyi Memorial Hospital).

Explore the full profile